| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Pathology, Academic Medical Center, 1105 AZ Amsterdam [L. A. S., R. J. B., J. A., W. M. A., C. J. M. v. N.], and Department of Pathology, Academic Hospital Groningen, Groningen [J. E. J. G.], the Netherlands
Activation-induced cytidine deaminase (AID) is essential for somatic hypermutation and class switch recombination of the immunoglobulin (IG) genes in B cells. It has recently been proposed that AID, as the newly identified DNA mutator in man, may be instrumental in initiation and progression of B-cell non-Hodgkins lymphomas (B-NHL). We quantitatively measured, by real-time reverse-transcription PCR, expression of AID and of the error-prone DNA polymerase
in normal B cells and a comprehensive panel of B-NHL entities. In pre- and postgerminal center (GC)-type B-NHLs like in normal naive and memory cells, AID did not exceed background levels. However, half of Burkitt lymphomas tested were found to express AID, at most at levels comparable with those found in normal GC B cells. Thirty percent of diffuse large B-cell lymphomas also transcribed AID, some at supraphysiological levels. Of follicular lymphoma cases, only 25% expressed significant amounts of AID. Moreover, within the group of GC-type B-NHLs, a statistically significant correlation between AID and polymerase
expression was found. By contrast, we observed no correlation between AID expression and mutation load neither with the degree of intraclonal diversity of IG variable heavy chain genes. Interestingly, in two of seven follicular lymphomas with clinical and histological progression, selective outgrowth of AID-expressing clones occurred, suggestive for a role of the somatic diversification machinery in lymphoma transformation.
This article has been cited by other articles:
![]() |
J. E. J. Guikema, E. Schuuring, and P. M. Kluin Structure and Consequences of IGH Switch Breakpoints in Burkitt Lymphoma J Natl Cancer Inst Monographs, July 1, 2008; 2008(39): 32 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Popov, G. Moldenhauer, B. Wotschke, S. Bruderlein, T. F. Barth, K. Dorsch, O. Ritz, P. Moller, and F. Leithauser Target Sequence Accessibility Limits Activation-Induced Cytidine Deaminase Activity in Primary Mediastinal B-Cell Lymphoma Cancer Res., July 15, 2007; 67(14): 6555 - 6564. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Kolar, D. Mehta, R. Pelayo, and J. D. Capra A novel human B cell subpopulation representing the initial germinal center population to express AID Blood, March 15, 2007; 109(6): 2545 - 2552. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kotani, N. Kakazu, T. Tsuruyama, I.-m. Okazaki, M. Muramatsu, K. Kinoshita, H. Nagaoka, D. Yabe, and T. Honjo Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice PNAS, January 30, 2007; 104(5): 1616 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Shen, D. O. Ferguson, M. Renard, K. K. Hoyer, U. Kim, X. Hao, F. W. Alt, R. G. Roeder, H. C. Morse III, and M. A. Teitell Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation Blood, September 15, 2006; 108(6): 1991 - 1998. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dijkman, C. P. Tensen, M. Buettner, G. Niedobitek, R. Willemze, and M. H. Vermeer Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID Blood, June 15, 2006; 107(12): 4926 - 4929. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kriangkum, B. J. Taylor, E. Strachan, M. J. Mant, T. Reiman, A. R. Belch, and L. M. Pilarski Impaired class switch recombination (CSR) in Waldenstrom macroglobulinemia (WM) despite apparently normal CSR machinery Blood, April 1, 2006; 107(7): 2920 - 2927. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Mottok, M-L Hansmann, and A Brauninger Activation induced cytidine deaminase expression in lymphocyte predominant Hodgkin lymphoma J. Clin. Pathol., September 1, 2005; 58(9): 1002 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Montesinos-Rongen, R. Schmitz, C. Courts, W. Stenzel, D. Bechtel, G. Niedobitek, I. Blumcke, G. Reifenberger, A. von Deimling, B. Jungnickel, et al. Absence of Immunoglobulin Class Switch in Primary Lymphomas of the Central Nervous System Am. J. Pathol., June 1, 2005; 166(6): 1773 - 1779. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. J. Guikema, S. Rosati, K. Akkermans, R. J. Bende, C. J. M. van Noesel, J. H. van Krieken, M. L. Hansmann, E. Schuuring, P. M. Kluin, S. S. Sahota, et al. Quantitative RT-PCR analysis of activation-induced cytidine deaminase expression in tissue samples from mantle cell lymphoma and B-cell chronic lymphocytic leukemia patients Blood, April 1, 2005; 105(7): 2997 - 2999. [Full Text] [PDF] |
||||
![]() |
A. S. Freedman Biology and Management of Histologic Transformation of Indolent Lymphoma Hematology, January 1, 2005; 2005(1): 314 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Q. Zhang, C. Okumura, T. McCarty, M. S. Shin, P. Mukhopadhyay, M. Hori, T. A. Torrey, Z. Naghashfar, J. X. Zhou, C. H. Lee, et al. Evidence for Selective Transformation of Autoreactive Immature Plasma Cells in Mice Deficient in Fasl J. Exp. Med., December 6, 2004; 200(11): 1467 - 1478. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Forconi, S. S. Sahota, D. Raspadori, M. Ippoliti, G. Babbage, F. Lauria, and F. K. Stevenson Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch Blood, November 15, 2004; 104(10): 3312 - 3317. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pasqualucci, R. Guglielmino, J. Houldsworth, J. Mohr, S. Aoufouchi, R. Polakiewicz, R. S. K. Chaganti, and R. Dalla-Favera Expression of the AID protein in normal and neoplastic B cells Blood, November 15, 2004; 104(10): 3318 - 3325. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Babbage, R. Garand, N. Robillard, N. Zojer, F. K. Stevenson, and S. S. Sahota Mantle cell lymphoma with t(11;14) and unmutated or mutated VH genes expresses AID and undergoes isotype switch events Blood, April 1, 2004; 103(7): 2795 - 2798. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |